US equities
|
META
$624.29
▼-0.99%
TSLA
$401.31
▲+2.47%
MU
$923.10
▲+2.15%
NVDA
$216.97
▲+0.45%
SPCX
$149.83
▲+1.99%
AMD
$551.45
▲+3.80%
SNDK
$1,292.20
▲+2.92%
INTC
$92.79
▲+2.56%
META
$624.29
▼-0.99%
TSLA
$401.31
▲+2.47%
MU
$923.10
▲+2.15%
NVDA
$216.97
▲+0.45%
SPCX
$149.83
▲+1.99%
AMD
$551.45
▲+3.80%
SNDK
$1,292.20
▲+2.92%
INTC
$92.79
▲+2.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Lexaria Bioscience Corp. - Common Stock
(NQ:
LEXX
)
2.910
-0.010 (-0.34%)
Delayed Quote
Updated: 9:30 AM EDT, Oct 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lexaria Bioscience Corp. - Common Stock
< Previous
1
2
...
27
28
29
30
31
32
33
34
Next >
Lexaria Commences Human Clinical Hypertension Study
April 22, 2021
- Study to examine DehydraTECHTM CBD's ability to control blood pressure - First of three human clinical studies hoped to validate Lexaria's patented technology for hypertension relief KELOWNA, BC /...
From
Lexaria Bioscience Corp.
Via
AccessWire
Topics
Intellectual Property
The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs
↗
April 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Ardelyx, Inc. (NASDAQ:...
Via
Benzinga
Lexaria Appoints New Chief Financial Officer and Issues Consultant Warrants
April 15, 2021
KELOWNA, BC / ACCESSWIRE / April 15, 2021 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces the...
From
Lexaria Bioscience Corp.
Via
AccessWire
Topics
Intellectual Property
Lexaria's DehydraTECHTM Technology Utilized in Amari's "Everyday Calm," Named a Top CBD Product Pick by New Hope Network
April 14, 2021
- DehydraTECHTM Powers Amari's Award-Winning Products KELOWNA, BC / ACCESSWIRE / April 14, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global...
From
Lexaria Bioscience Corp.
Via
AccessWire
Topics
Intellectual Property
Supply Chain
Lexaria Is Expanding CBD Use Beyond Medical Applications into $2.65 Billion Marketplace
April 08, 2021
New York, New York--(Newsfile Corp. - April 8, 2021) - PCG Digital -- The team at Lexaria Bioscience (NASDAQ: LEXX),...
Via
Newsfile
Topics
Cannabis
Intellectual Property
< Previous
1
2
...
27
28
29
30
31
32
33
34
Next >